Shandong Xinhua Pharmaceutical Company Limited (XIN) — Free Cash Flow Generation Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Free Cash Flow Generation Index of -0.44x as of September 2023. Free cash flow of €-24.58 Million represents 0% of operating cash flow (€56.11 Million). Read Shandong Xinhua Pharmaceutical Company L (XIN) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Explore XIN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for Shandong Xinhua Pharmaceutical Company Limited. For the full company profile including market capitalisation, see XIN market cap.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | €418.13 Million | €533.73 Million | €115.60 Million | ▲ +85.6% |
| 2024 | 0.42x | €155.19 Million | €367.61 Million | €212.42 Million | ▲ +287.1% |
| 2023 | -0.23x | €-59.85 Million | €265.28 Million | €325.13 Million | ▼ -133.3% |
| 2022 | 0.68x | €513.48 Million | €758.24 Million | €244.76 Million | ▲ +1674.3% |
| 2021 | 0.04x | €9.89 Million | €259.12 Million | €249.23 Million | ▼ -88.5% |
| 2020 | 0.33x | €140.00 Million | €420.19 Million | €280.19 Million | ▲ +736.1% |
| 2019 | -0.05x | €-18.24 Million | €348.27 Million | €366.51 Million | ▲ +59.0% |
| 2018 | -0.13x | €-41.38 Million | €323.91 Million | €388.44 Million | ▼ -138.7% |
| 2017 | 0.33x | €128.86 Million | €389.97 Million | €261.11 Million | ▼ -78.2% |
| 2016 | 1.52x | €666.42 Million | €439.35 Million | €227.07 Million | ▲ +2.1% |
| 2015 | 1.48x | €517.72 Million | €348.64 Million | €169.09 Million | ▼ -15.2% |
| 2014 | 1.75x | €606.51 Million | €346.34 Million | €260.17 Million | ▼ -59.1% |
| 2013 | 4.28x | €449.52 Million | €104.99 Million | €344.53 Million | — |